NovaRadar Investment Team Attends the 2026 Asia Biotech Industry Forum

NovaRadar Bio Venture's investment team was invited to attend the 2026 Asia Biotech Industry Forum, exchanging insights with representatives from international biotech investment institutions and sharing the company's investment perspective and track record in new drug development and precision medicine.